The global Point-of-care Infectious Disease Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Point-of-care Infectious Disease Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-of-care Infectious Disease Diagnostics.

Report Scope

The Point-of-care Infectious Disease Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Point-of-care Infectious Disease Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Point-of-care Infectious Disease Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Point-of-care Infectious Disease Diagnostics Market Report

Report Metric	Details
Report Name	Point-of-care Infectious Disease Diagnostics Market
CAGR	5%
Segment by Type	HIV POC Clostridium Difficile POC HBV POC Respiratory Syncytial Virus POC HPV POC Influenza/Flu POC HCV POC MRSA POC TB and Drug-Resistant TB POC
Segment by Application	Hospitals Clinics Home Assisted Living Healthcare Facilities Laboratories Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, Abbott, Calypte Biomedical, Chembio Diagnostic Systems, Meridian Bioscience, MedMira, Trinity Biotech, Sekisui Diagnostics, OraSure Technologies, Quidel
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point-of-care Infectious Disease Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Point-of-care Infectious Disease Diagnostics Market report?

Ans: The main players in the Point-of-care Infectious Disease Diagnostics Market are Thermo Fisher Scientific, Abbott, Calypte Biomedical, Chembio Diagnostic Systems, Meridian Bioscience, MedMira, Trinity Biotech, Sekisui Diagnostics, OraSure Technologies, Quidel

What are the Application segmentation covered in the Point-of-care Infectious Disease Diagnostics Market report?

Ans: The Applications covered in the Point-of-care Infectious Disease Diagnostics Market report are Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others

What are the Type segmentation covered in the Point-of-care Infectious Disease Diagnostics Market report?

Ans: The Types covered in the Point-of-care Infectious Disease Diagnostics Market report are HIV POC, Clostridium Difficile POC, HBV POC, Respiratory Syncytial Virus POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, TB and Drug-Resistant TB POC

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 HIV POC

1.2.3 Clostridium Difficile POC

1.2.4 HBV POC

1.2.5 Respiratory Syncytial Virus POC

1.2.6 HPV POC

1.2.7 Influenza/Flu POC

1.2.8 HCV POC

1.2.9 MRSA POC

1.2.10 TB and Drug-Resistant TB POC

1.3 Market by Application

1.3.1 Global Point-of-care Infectious Disease Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Home

1.3.5 Assisted Living Healthcare Facilities

1.3.6 Laboratories

1.3.7 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Point-of-care Infectious Disease Diagnostics Market Perspective (2019-2030)

2.2 Point-of-care Infectious Disease Diagnostics Growth Trends by Region

2.2.1 Global Point-of-care Infectious Disease Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Point-of-care Infectious Disease Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 Point-of-care Infectious Disease Diagnostics Market Dynamics

2.3.1 Point-of-care Infectious Disease Diagnostics Industry Trends

2.3.2 Point-of-care Infectious Disease Diagnostics Market Drivers

2.3.3 Point-of-care Infectious Disease Diagnostics Market Challenges

2.3.4 Point-of-care Infectious Disease Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Point-of-care Infectious Disease Diagnostics Players by Revenue

3.1.1 Global Top Point-of-care Infectious Disease Diagnostics Players by Revenue (2019-2024)

3.1.2 Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global Point-of-care Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Point-of-care Infectious Disease Diagnostics Revenue

3.4 Global Point-of-care Infectious Disease Diagnostics Market Concentration Ratio

3.4.1 Global Point-of-care Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Point-of-care Infectious Disease Diagnostics Revenue in 2023

3.5 Point-of-care Infectious Disease Diagnostics Key Players Head office and Area Served

3.6 Key Players Point-of-care Infectious Disease Diagnostics Product Solution and Service

3.7 Date of Enter into Point-of-care Infectious Disease Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Point-of-care Infectious Disease Diagnostics Breakdown Data by Type

4.1 Global Point-of-care Infectious Disease Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Type (2025-2030)

5 Point-of-care Infectious Disease Diagnostics Breakdown Data by Application

5.1 Global Point-of-care Infectious Disease Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Point-of-care Infectious Disease Diagnostics Market Size (2019-2030)

6.2 North America Point-of-care Infectious Disease Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2019-2024)

6.4 North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Point-of-care Infectious Disease Diagnostics Market Size (2019-2030)

7.2 Europe Point-of-care Infectious Disease Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2019-2024)

7.4 Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size (2019-2030)

8.2 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2019-2024)

8.4 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Point-of-care Infectious Disease Diagnostics Market Size (2019-2030)

9.2 Latin America Point-of-care Infectious Disease Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2019-2024)

9.4 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size (2019-2030)

10.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2019-2024)

10.4 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Detail

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Introduction

11.1.4 Thermo Fisher Scientific Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Abbott

11.2.1 Abbott Company Detail

11.2.2 Abbott Business Overview

11.2.3 Abbott Point-of-care Infectious Disease Diagnostics Introduction

11.2.4 Abbott Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024)

11.2.5 Abbott Recent Development

11.3 Calypte Biomedical

11.3.1 Calypte Biomedical Company Detail

11.3.2 Calypte Biomedical Business Overview

11.3.3 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Introduction

11.3.4 Calypte Biomedical Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024)

11.3.5 Calypte Biomedical Recent Development

11.4 Chembio Diagnostic Systems

11.4.1 Chembio Diagnostic Systems Company Detail

11.4.2 Chembio Diagnostic Systems Business Overview

11.4.3 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Introduction

11.4.4 Chembio Diagnostic Systems Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024)

11.4.5 Chembio Diagnostic Systems Recent Development

11.5 Meridian Bioscience

11.5.1 Meridian Bioscience Company Detail

11.5.2 Meridian Bioscience Business Overview

11.5.3 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Introduction

11.5.4 Meridian Bioscience Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024)

11.5.5 Meridian Bioscience Recent Development

11.6 MedMira

11.6.1 MedMira Company Detail

11.6.2 MedMira Business Overview

11.6.3 MedMira Point-of-care Infectious Disease Diagnostics Introduction

11.6.4 MedMira Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024)

11.6.5 MedMira Recent Development

11.7 Trinity Biotech

11.7.1 Trinity Biotech Company Detail

11.7.2 Trinity Biotech Business Overview

11.7.3 Trinity Biotech Point-of-care Infectious Disease Diagnostics Introduction

11.7.4 Trinity Biotech Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024)

11.7.5 Trinity Biotech Recent Development

11.8 Sekisui Diagnostics

11.8.1 Sekisui Diagnostics Company Detail

11.8.2 Sekisui Diagnostics Business Overview

11.8.3 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Introduction

11.8.4 Sekisui Diagnostics Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024)

11.8.5 Sekisui Diagnostics Recent Development

11.9 OraSure Technologies

11.9.1 OraSure Technologies Company Detail

11.9.2 OraSure Technologies Business Overview

11.9.3 OraSure Technologies Point-of-care Infectious Disease Diagnostics Introduction

11.9.4 OraSure Technologies Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024)

11.9.5 OraSure Technologies Recent Development

11.10 Quidel

11.10.1 Quidel Company Detail

11.10.2 Quidel Business Overview

11.10.3 Quidel Point-of-care Infectious Disease Diagnostics Introduction

11.10.4 Quidel Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024)

11.10.5 Quidel Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Thermo Fisher Scientific

Abbott

Calypte Biomedical

Chembio Diagnostic Systems

List of Tables

Table 1. Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of HIV POC

Table 3. Key Players of Clostridium Difficile POC

Table 4. Key Players of HBV POC

Table 5. Key Players of Respiratory Syncytial Virus POC

Table 6. Key Players of HPV POC

Table 7. Key Players of Influenza/Flu POC

Table 8. Key Players of HCV POC

Table 9. Key Players of MRSA POC

Table 10. Key Players of TB and Drug-Resistant TB POC

Table 11. Global Point-of-care Infectious Disease Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 12. Global Point-of-care Infectious Disease Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 13. Global Point-of-care Infectious Disease Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 14. Global Point-of-care Infectious Disease Diagnostics Market Share by Region (2019-2024)

Table 15. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 16. Global Point-of-care Infectious Disease Diagnostics Market Share by Region (2025-2030)

Table 17. Point-of-care Infectious Disease Diagnostics Market Trends

Table 18. Point-of-care Infectious Disease Diagnostics Market Drivers

Table 19. Point-of-care Infectious Disease Diagnostics Market Challenges

Table 20. Point-of-care Infectious Disease Diagnostics Market Restraints

Table 21. Global Point-of-care Infectious Disease Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 22. Global Point-of-care Infectious Disease Diagnostics Market Share by Players (2019-2024)

Table 23. Global Top Point-of-care Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Infectious Disease Diagnostics as of 2023)

Table 24. Ranking of Global Top Point-of-care Infectious Disease Diagnostics Companies by Revenue (US$ Million) in 2023

Table 25. Global 5 Largest Players Market Share by Point-of-care Infectious Disease Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 26. Key Players Headquarters and Area Served

Table 27. Key Players Point-of-care Infectious Disease Diagnostics Product Solution and Service

Table 28. Date of Enter into Point-of-care Infectious Disease Diagnostics Market

Table 29. Mergers & Acquisitions, Expansion Plans

Table 30. Global Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 31. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type (2019-2024)

Table 32. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 33. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type (2025-2030)

Table 34. Global Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 35. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Application (2019-2024)

Table 36. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 37. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Application (2025-2030)

Table 38. North America Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 40. North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 41. Europe Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 43. Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 44. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 45. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 46. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 47. Latin America Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 49. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 50. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 51. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 52. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 53. Thermo Fisher Scientific Company Detail

Table 54. Thermo Fisher Scientific Business Overview

Table 55. Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Product

Table 56. Thermo Fisher Scientific Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 57. Thermo Fisher Scientific Recent Development

Table 58. Abbott Company Detail

Table 59. Abbott Business Overview

Table 60. Abbott Point-of-care Infectious Disease Diagnostics Product

Table 61. Abbott Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 62. Abbott Recent Development

Table 63. Calypte Biomedical Company Detail

Table 64. Calypte Biomedical Business Overview

Table 65. Calypte Biomedical Point-of-care Infectious Disease Diagnostics Product

Table 66. Calypte Biomedical Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 67. Calypte Biomedical Recent Development

Table 68. Chembio Diagnostic Systems Company Detail

Table 69. Chembio Diagnostic Systems Business Overview

Table 70. Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Product

Table 71. Chembio Diagnostic Systems Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 72. Chembio Diagnostic Systems Recent Development

Table 73. Meridian Bioscience Company Detail

Table 74. Meridian Bioscience Business Overview

Table 75. Meridian Bioscience Point-of-care Infectious Disease Diagnostics Product

Table 76. Meridian Bioscience Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 77. Meridian Bioscience Recent Development

Table 78. MedMira Company Detail

Table 79. MedMira Business Overview

Table 80. MedMira Point-of-care Infectious Disease Diagnostics Product

Table 81. MedMira Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 82. MedMira Recent Development

Table 83. Trinity Biotech Company Detail

Table 84. Trinity Biotech Business Overview

Table 85. Trinity Biotech Point-of-care Infectious Disease Diagnostics Product

Table 86. Trinity Biotech Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 87. Trinity Biotech Recent Development

Table 88. Sekisui Diagnostics Company Detail

Table 89. Sekisui Diagnostics Business Overview

Table 90. Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Product

Table 91. Sekisui Diagnostics Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 92. Sekisui Diagnostics Recent Development

Table 93. OraSure Technologies Company Detail

Table 94. OraSure Technologies Business Overview

Table 95. OraSure Technologies Point-of-care Infectious Disease Diagnostics Product

Table 96. OraSure Technologies Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 97. OraSure Technologies Recent Development

Table 98. Quidel Company Detail

Table 99. Quidel Business Overview

Table 100. Quidel Point-of-care Infectious Disease Diagnostics Product

Table 101. Quidel Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 102. Quidel Recent Development

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Point-of-care Infectious Disease Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Point-of-care Infectious Disease Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. HIV POC Features

Figure 4. Clostridium Difficile POC Features

Figure 5. HBV POC Features

Figure 6. Respiratory Syncytial Virus POC Features

Figure 7. HPV POC Features

Figure 8. Influenza/Flu POC Features

Figure 9. HCV POC Features

Figure 10. MRSA POC Features

Figure 11. TB and Drug-Resistant TB POC Features

Figure 12. Global Point-of-care Infectious Disease Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 13. Global Point-of-care Infectious Disease Diagnostics Market Share by Application: 2023 VS 2030

Figure 14. Hospitals Case Studies

Figure 15. Clinics Case Studies

Figure 16. Home Case Studies

Figure 17. Assisted Living Healthcare Facilities Case Studies

Figure 18. Laboratories Case Studies

Figure 19. Others Case Studies

Figure 20. Point-of-care Infectious Disease Diagnostics Report Years Considered

Figure 21. Global Point-of-care Infectious Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 22. Global Point-of-care Infectious Disease Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 23. Global Point-of-care Infectious Disease Diagnostics Market Share by Region: 2023 VS 2030

Figure 24. Global Point-of-care Infectious Disease Diagnostics Market Share by Players in 2023

Figure 25. Global Top Point-of-care Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Infectious Disease Diagnostics as of 2023)

Figure 26. The Top 10 and 5 Players Market Share by Point-of-care Infectious Disease Diagnostics Revenue in 2023

Figure 27. North America Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. North America Point-of-care Infectious Disease Diagnostics Market Share by Country (2019-2030)

Figure 29. United States Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Canada Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Europe Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Europe Point-of-care Infectious Disease Diagnostics Market Share by Country (2019-2030)

Figure 33. Germany Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. France Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. U.K. Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Italy Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Russia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Nordic Countries Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Share by Region (2019-2030)

Figure 41. China Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Japan Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Latin America Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Latin America Point-of-care Infectious Disease Diagnostics Market Share by Country (2019-2030)

Figure 49. Mexico Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Brazil Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Share by Country (2019-2030)

Figure 53. Turkey Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2019-2024)

Figure 56. Abbott Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2019-2024)

Figure 57. Calypte Biomedical Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2019-2024)

Figure 58. Chembio Diagnostic Systems Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2019-2024)

Figure 59. Meridian Bioscience Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2019-2024)

Figure 60. MedMira Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2019-2024)

Figure 61. Trinity Biotech Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2019-2024)

Figure 62. Sekisui Diagnostics Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2019-2024)

Figure 63. OraSure Technologies Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2019-2024)

Figure 64. Quidel Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions